Physician profile
Gregory R Martens
NPI 1316201940
$1,648.26
in general payments reported to CMS, 2019-2025
10 companies · $272 in 2025
The $272 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $224 · 2022: $653 · 2023: $205 · 2024: $295 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $772.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $486.33 | 2021-2023 | Floseal |
| United Therapeutics Corporation | $386.93 | 2024-2025 | Steen Solution, Steen Solution, Tyvaso |
| Sanofi-Aventis U.S. LLC | $201.75 | 2021-2022 | |
| Intuitive Surgical, INC. | $165.11 | 2024-2025 | |
| Genzyme Corporation | $138.89 | 2022 | |
| Veloxis Pharmaceuticals, INC. | $129.87 | 2022 | |
| Organox Ltd | $83.33 | 2023 | Metra |
| Ethicon US, LLC | $22.74 | 2022 | |
| Medtronic, INC. | $18.48 | 2021 | |
| Kamada Ltd. | $14.83 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Martens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.